Renub Research

Blood Glucose Device Market is expected to US$ 20 Billion by the end of the year 2025

Press release   •   Sep 20, 2019 06:02 EDT

According to International diabetes federation, in 2017, there are around 425 million of people living with diabetes in the world. Diabetes people all over the world use glucose meter, test strips and lancing device to measure the blood glucose level. There are many diabetes patients especially insulin dependent that has severe hypoglycemic and hyperglycemic index level. They use 3-4 or even more than that strips on the daily basis to monitor the blood glucose level. As monitoring blood glucose is an essential part of diabetes management. Moreover, SMBG device are convenient to use at any point of time before breakfast, before meal, after meal and before –after exercise. According to Renub Research the Global Blood Glucose Device Market is expected to surpass US$ 20 Billion mark by the end of the year 2025.

The SMBG market is growing with rapid pace due to numerous key factors like rising global diabetes population (type 1 diabetes and type 2 diabetes), increasing insulin dependent diabetes population, increasing obese population, rise in ageing population, rising awareness regarding diabetes and technological advancement of SMBG device that makes convenience for patient to easily measure blood glucose level.

China has the Highest Diabetes Population in the World

Diabetes prevalence in China has been growing with rapid pace and it become one of the largest diabetes country in the world. Nearly 114 million people affected with diabetes in China but the prevalence of SMBG user in China was quite low as compared to developed countries. Changing lifestyle and food habits is the key reason to increase diabetes population in China.

Access full Research:

https://www.renub.com/blood-glucose-device-market-and-forecast-smbg-test-strips-lancet-meter-worldwide-analysis-977-p.php

In this report, we have taken diabetes population of 17 countries; United States, United Kingdom, India, Netherlands, Germany, Australia, Spain, Russia, Brazil, Kuwait, Switzerland, China, Italy, Norway, Sweden, South Africa and Saudi Arabia etc. here we have fragmented diabetes population of each country into two parts; Type 1 Diabetes and Type 2 Diabetes.

Self-Monitoring Blood Glucose Devices Insight

In this report, we have done comprehensive analysis of SMBG user like; their frequency of utilizing test-strips, its market and number of people that uses device. SMBG is mainly used by type 1 diabetes population and insulin user of type 2 diabetes to monitor their blood glucose. In addition, the people those are facing hypoglycemia and hyperglycemia are also frequent user of SMBG device. In this report, we have divided SMBG user into two parts; type 1 diabetes user and type 2 diabetes users. Here SMBG report constitutes three components; Test Strips, Lancet Device and Glucose Meter.

Request a free sample copy of the report:

https://www.renub.com/request-sample-page.php?gturl=blood-glucose-device-market-and-forecast-smbg-test-strips-lancet-meter-worldwide-analysis-977-p.php


Blood Glucose Device Market - 17 Countries Covered in this Report:

America

1. United States
2. Brazil

Europe

3. United Kingdom
4. Germany
5. Spain
6. Italy
7. Netherlands
8. Norway
9. Sweden
10. Switzerland
11. Russia

Asia & Pacific

12. India
13. China
14. Australia

Middle East & Africa

15. Kuwait
16. Saudi Arabia
17. South Africa

“Blood Glucose Device Market, Users Global Forecast, SMBG Components (Test Strips, Lancet, Meter) of 17 Countries (USA, Europe, Asia & Pacific, Middle East & Africa) & Companies (Roche, LifeScan Inc. Bayer HealthCare, Abbott)” analyzes the worldwide market for, blood glucose test strips market, blood glucose lancet market and blood glucose meter market. This is the 5th publication on Blood Glucose Device Market by Renub Research.

This report studies the separate comprehensive analytics for the 17 countries: United States, European Countries (United Kingdom, Germany, Spain, Italy, Netherlands, Norway, Sweden and Switzerland), BRIC countries (Brazil, Russia, India, China), Australia and Kuwait. Annual estimates and forecast are provided for the period of 2019 through 2025. A six year historic analysis is also provided for these markets.

Company Analysis

1. Roche Diagnostic
2. LifeScan Inc.,
3. Bayer HealthCare
4. Abbott Laboratories

All the 4 Companies Studied in the Report have been Studied from 3 Points

  • Company Overview
  • Recent Developments
  • Financial Insight

If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.

Contact Us

Email: info@renub.com

Phone: +1-678-302-0700

Web: www.renub.com

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises of major players in Life Sciences, Information Technology, Telecom, Financial Services (Banking, Insurance), Energy, Retail, Manufacturing, Automotive, and Social sector. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.